• Explore /
  • Poster
  • / Survival study of neoadjuvant versus adjuvant chemotherapy with docetaxel combined carboplatin in resectable stage IB to IIIA non-small lung cancer.

Survival study of neoadjuvant versus adjuvant chemotherapy with docetaxel combined carboplatin in resectable stage IB to IIIA non-small lung cancer.

Abstract Poster

Authors

Xue-ning Yang

Xue-Ning Yang

Guangdong Lung Cancer Institute, Guangdong General Hospital and Guangdong Academy of Medical Sciences, Guangzhou, China

Xue-Ning Yang , Gang Cheng , Xiao-song Ben , Hong-He Luo , Chang-li Wang , Wenzhao Zhong , Di Ge , Gui-bin Qiao , Zheng Wang , Yang Shentu , Jie Yang , Hong hong Yan , Yi Long Wu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT00321334

Citation

J Clin Oncol 31, 2013 (suppl; abstr 7537)

DOI

10.1200/jco.2013.31.15_suppl.7537

Abstract #

7537

Poster Bd #

19G

Abstract Disclosures

Similar Posters

First Author: Xue-ning Yang

First Author: Winston Wong

First Author: Fangchao Zheng

First Author: Tina Cascone